Related Experiment Video
Updated: Feb 3, 2026
09:22
Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish
Published on: April 25, 2017
17.4K
7,8-Dihydroxy-3-arylcoumarin Induces Cell Death Through S-Phase Arrest in MDA-MB-231 Breast Cancer Cells
Musiliyu A Musa1, Veera L D Badisa2, Lekan M Latinwo2
1Department of Chemistry, Florida A&M University, Tallahassee, FL, U.S.A. musiliyu.musa@famu.edu.
Anticancer Research
|November 7, 2018
Summary
The coumarin derivative 7h demonstrated potent anticancer activity against breast cancer cells (MDA-MB-231). This compound induced cell cycle arrest, highlighting its potential for developing new breast cancer therapeutics.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Cancer Biology
Background:
- Coumarins are a versatile class of compounds extensively utilized in anticancer drug design.
- The study focuses on evaluating novel 7,8-dihydroxy-3-arylcoumarin derivatives for their cytotoxic potential.
Purpose of the Study:
- To assess the in vitro cytotoxic activity of synthesized 7,8-dihydroxy-3-arylcoumarin derivatives (7a-i).
- To investigate the efficacy of these compounds against A549 (lung), MDA-MB-231 (breast), and PC-3 (prostate) cancer cell lines.
Main Methods:
- Cytotoxic activity was evaluated using the crystal violet dye-binding assay.
- Cell-cycle progression and regulatory protein expression were analyzed via flow cytometry and western blot analysis.
Main Results:
- Compound 7h, 7,8-diacetoxy-3-(4-nitrophenyl)coumarin, exhibited the highest cytotoxicity against MDA-MB-231 cells (CC50 of 7.51±0.07 μM).
- Compound 7h induced significant S-phase and moderate G2/M phase cell cycle arrest in MDA-MB-231 cells.
- Key regulatory proteins involved in cell cycle progression, including cyclins and CDKs, were modulated by compound 7h.
Conclusions:
- The coumarin derivative 7h shows significant potential as a lead compound for novel breast cancer drug development.
- Further research into 7h and its derivatives could lead to new therapeutic strategies for breast cancer treatment.
Related Concept Videos
01:18Autophagic Cell Death
4.5K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.5K
01:30Overview of Cell Death
9.9K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.9K
01:13Induced Pluripotent Stem Cells
28.0K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.0K
01:06Induced Pluripotent Stem Cells
5.6K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.6K
01:35Cancer Cell Migration through Invadopodia
3.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K
02:53Adaptive Mechanisms in Cancer Cells
7.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.1K